Product

Florbetapir F 18

1 clinical trial

1 indication

Indication

Alzheimer's disease

Clinical trial

Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease

Status: Completed, Estimated PCD: 2019-06-05